Xiaozhe Yin

661 total citations
10 papers, 476 citations indexed

About

Xiaozhe Yin is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Xiaozhe Yin has authored 10 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Immunology. Recurrent topics in Xiaozhe Yin's work include Immunotherapy and Immune Responses (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and vaccines and immunoinformatics approaches (1 paper). Xiaozhe Yin is often cited by papers focused on Immunotherapy and Immune Responses (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and vaccines and immunoinformatics approaches (1 paper). Xiaozhe Yin collaborates with scholars based in China and United States. Xiaozhe Yin's co-authors include Wei Liang, Wenfeng Zeng, Fayun Zhang, Luoyang Wang, Dingchao Chen, Jinghai Xu, Lingtao Jin, Xiuli Wei, Qin Yan and Luyao Wang and has published in prestigious journals such as Nature Communications, The Journal of Immunology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Xiaozhe Yin

10 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaozhe Yin China 7 196 114 89 71 63 10 476
Yongjun Tang China 20 308 1.6× 157 1.4× 67 0.8× 9 0.1× 12 0.2× 56 941
Pengjun Zhao China 15 317 1.6× 122 1.1× 21 0.2× 5 0.1× 11 0.2× 31 1.2k
Yijun Huang China 13 224 1.1× 57 0.5× 48 0.5× 28 0.4× 3 0.0× 38 543
Xiujie Chen China 15 507 2.6× 228 2.0× 28 0.3× 3 0.0× 18 0.3× 51 899
Qinhua Wang China 13 196 1.0× 75 0.7× 20 0.2× 2 0.0× 11 0.2× 31 701
Michael A. Christiansen United States 11 100 0.5× 32 0.3× 40 0.4× 2 0.0× 18 0.3× 32 601
Cheng Zhu China 13 94 0.5× 33 0.3× 14 0.2× 8 0.1× 3 0.0× 42 579
Lina Xu China 14 264 1.3× 73 0.6× 44 0.5× 15 0.2× 32 948
Dihua Li China 19 368 1.9× 78 0.7× 137 1.5× 1 0.0× 11 0.2× 64 1.1k
Sirui Huang China 10 202 1.0× 148 1.3× 18 0.2× 12 0.2× 27 400

Countries citing papers authored by Xiaozhe Yin

Since Specialization
Citations

This map shows the geographic impact of Xiaozhe Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaozhe Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaozhe Yin more than expected).

Fields of papers citing papers by Xiaozhe Yin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaozhe Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaozhe Yin. The network helps show where Xiaozhe Yin may publish in the future.

Co-authorship network of co-authors of Xiaozhe Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaozhe Yin. A scholar is included among the top collaborators of Xiaozhe Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaozhe Yin. Xiaozhe Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Yin, Xiaozhe, Zexuan Ding, Yu Li, et al.. (2025). Orchestrating intratumoral DC-T cell immunity for enhanced tumor control via radiotherapy-activated TLR7/8 prodrugs in mice. Nature Communications. 16(1). 6020–6020. 5 indexed citations
2.
Ding, Zexuan, Xiaozhe Yin, Yiyan Li, et al.. (2025). Single atom engineering for radiotherapy-activated immune agonist prodrugs. Nature Communications. 16(1). 6021–6021. 3 indexed citations
3.
Zeng, Wenfeng, et al.. (2021). PPARα at the crossroad of metabolic–immune regulation in cancer. FEBS Journal. 289(24). 7726–7739. 35 indexed citations
4.
Yin, Xiaozhe, Wenfeng Zeng, Bowen Wu, et al.. (2020). PPARα Inhibition Overcomes Tumor-Derived Exosomal Lipid-Induced Dendritic Cell Dysfunction. Cell Reports. 33(3). 108278–108278. 131 indexed citations
5.
Wang, Luoyang, Wenfeng Zeng, Luyao Wang, et al.. (2019). Naringenin Enhances the Antitumor Effect of Therapeutic Vaccines by Promoting Antigen Cross-Presentation. The Journal of Immunology. 204(3). 622–631. 20 indexed citations
6.
Zhang, Chao, Wenfeng Zeng, Yi Yao, et al.. (2018). Naringenin Ameliorates Radiation-Induced Lung Injury by Lowering IL-1β Level. Journal of Pharmacology and Experimental Therapeutics. 366(2). 341–348. 40 indexed citations
7.
Zhao, Na, et al.. (2017). Spatio-temporal changes in precipitation over Beijing-Tianjin-Hebei region, China. Atmospheric Research. 202. 156–168. 53 indexed citations
8.
Zhang, Fayun, Wenjuan Dong, Wenfeng Zeng, et al.. (2016). Naringenin prevents TGF-β1 secretion from breast cancer and suppresses pulmonary metastasis by inhibiting PKC activation. Breast Cancer Research. 18(1). 38–38. 82 indexed citations
9.
Xu, Jinghai, et al.. (2016). Multi-criteria location model of earthquake evacuation shelters to aid in urban planning. International Journal of Disaster Risk Reduction. 20. 51–62. 101 indexed citations
10.
Yin, Xiaozhe, et al.. (2013). Application of Mobile Learning System in Operating System Course. Communications and Network. 5(2). 157–160. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026